Retention · healthcare · LATAMJul 202610 min read336 words

Retention and expansion trends to watch in 2026 for healthcare and life sciences in Latin America

The seven shifts changing retention and expansion in 2026 — what to lean into, what to ignore, and what to prepare for by 2027. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Latin America.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install retention and expansion has to be shaped to that reality from day one.

Retention and expansion in 2026 is not the same discipline it was in 2024. Seven shifts are worth naming, three of them worth acting on this quarter.

Shift one: buyers reward specificity more than ever. Generic coverage is now negative signal, not neutral. This is the single biggest lever change.

Shift two: tooling is consolidating. The horizontal all-in-one platforms are absorbing the point tools; plan for fewer vendors and more integrated data.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Retention and expansion is only useful here when it is pointed at both constraints at once.

Shift three: AI is now assumed. The differentiator has moved from having AI to running it under a disciplined operating model.

Shift four: gross and net revenue retention is becoming a board-level metric across categories. Instrument it whether or not your board asks yet.

Shifts five to seven affect specific segments — enterprise governance, category creation, and vertical specialisation. Read them if they touch your business; ignore them if they do not.

The trend most likely to bite: treating CS as a support cost centre, dressed up in whatever this year's language happens to be. Watch for it.

Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing retention and expansion deliberately for this market rather than importing a playbook designed for somewhere else.

net revenue retentionSaaS expansionchurn reductionnet revenue retention trendsnet revenue retention 2026net revenue retention for healthcare and life sciencesnet revenue retention in Latin Americahealthcare and life sciences growth in Latin America

Frequently asked questions

Retention · healthcare · LATAM — answered

Does retention and expansion work for healthcare and life sciences in Latin America?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms. The healthcare teams that install this get past procurement instead of dying in it.
What is the biggest retention and expansion trend for 2026?
Buyers rewarding specificity. Generic coverage now works against you.
Is AI still a differentiator in retention and expansion?
Having AI is not; running it well is.
Should I switch vendors given the consolidation trend?
Only if your current stack is holding back gross and net revenue retention. Otherwise wait.
Which trend is safe to ignore?
Any trend that is not connected to a specific metric moving in your business.
What is the LATAM-specific pitfall when running retention and expansion for healthcare?
Importing a playbook that was built for another market. In Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms — the install has to reflect that.

Growth Broker editorial

Filed under retention · healthcare · latam

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call